Related Experiment Video
Updated: Jun 18, 2025

07:20
Author Spotlight: Imaging ATG9A, a Multi-Spanning Membrane Protein
Published on: June 16, 2023
2.0K
TMEM9 activates Rab9-dependent alternative autophagy through interaction with Beclin1
Sohyeon Baek1, Jae-Woong Chang2,3, Seung-Min Yoo2
1Department of Biological Sciences and Biotechnology, Chungbuk National University, Cheongju, 28644, South Korea.
Cellular and Molecular Life Sciences : CMLS
|July 30, 2024
Summary
Transmembrane protein 9 (TMEM9) regulates alternative autophagy by interacting with Beclin1, dissociating the inhibitor Bcl-2. This process is essential for lysosomal function and autophagy activation.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Transmembrane protein 9 (TMEM9) is known to regulate lysosomal acidification via interaction with the v-type ATPase complex.
- The specific role of TMEM9 within the lysosome-dependent autophagy pathway remains largely uncharacterized.
Purpose of the Study:
- To elucidate the function of TMEM9 in the autophagy machinery.
- To investigate the interaction of TMEM9 with key autophagy regulators, specifically Beclin1.
- To determine the mechanism by which TMEM9 influences autophagy, particularly alternative autophagy pathways.
Main Methods:
- Investigated the interaction between the cytosolic domain of TMEM9 and Beclin1 using biochemical assays.
- Utilized colocalization studies to examine the localization of TMEM9 with Rab9 and LC3 in late endosomes and lysosomes.
- Assessed the role of TMEM9 glycosylation in its lysosomal localization, Beclin1 interaction, and autophagy activation.
Main Results:
- TMEM9 directly interacts with Beclin1 through its Bcl-2-binding domain, leading to the dissociation of the autophagy inhibitor Bcl-2.
- TMEM9 colocalizes with Rab9 on late endosomes and lysosomes, but not with LC3, indicating involvement in LC3-independent autophagy.
- Glycosylation of TMEM9 is crucial for its lysosomal targeting, Beclin1 interaction, and subsequent activation of Rab9-dependent alternative autophagy.
Conclusions:
- TMEM9 acts as a crucial regulator of Rab9-dependent alternative autophagy.
- TMEM9 facilitates autophagy by recruiting and activating the Beclin1 complex at Rab9-dependent autophagosomes.
- These findings reveal a novel mechanism linking lysosomal function and autophagy regulation through TMEM9.
Related Concept Videos
Rab Proteins
3.9K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
3.9K
Rab Cascades
2.6K
Rab GTPases act in a regulated cascade during membrane fusion, helping the lipid bilayers mix. The Rab family of proteins are active when bound to GTP, and inactive when bound to GDP. Hence, they act as guanine nucleotide-dependent molecular switches. Rab-GTP recognizes and binds to long or short-range tethering proteins to capture the target vesicle. These tethers coordinate with SNAREs on the vesicle and the target membrane to assemble the trans SNARE complex that locks the mixing bilayers.
2.6K
Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Autophagy
4.2K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K

